GL1X · GenesisL1 explorer

MolNFT v1 · #188936 · protein

Crystal structure of C-terminal domain of MSK1 in complex with in covalently bound literature RSK2 inhibitor pyrrolopyrimidine cyanoacrylamide compound 25 (co-crystal)

7UP6: “Crystal structure of C-terminal domain of MSK1 in complex with in covalently bound literature RSK2 inhibitor…”. X-ray diffraction, 2 ligands (OXM, SUU). MolNFT v1 #188936 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
7UP6
Type
protein
Length
257 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
UniProt
O75582
Ligands
OXM, SUU

Structure

x-ray diffraction · 1 distinct chain.

ChainMoleculeTypeResiduesSecondary structureUniProt
A—protein257—O75582

Ligands and binding sites

  • OXM · Oxamic acid · ligand · 2 copies · chains A
  • SUU · (E)-3-(3-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)phenyl)-2-cyanoacrylamide bound form · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 7UP6 · Crystal structure of C-terminal domain of MSK1 in complex with in covalently bound… · the same entry in another collection · chain A against A, TM-score 1.00
  • O75582 · AlphaFold monomer V2.0 prediction for ribosomal protein S6 kinase alpha-5 (O75582) · a predicted model of the same protein · chain A against A, TM-score 0.96

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.